TTrialPathMatch Me to Trials
← Back to trials
RecruitingStrokeAtrial Fibrillation

Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress

Eligible age

55+ yrs

Accepts

All genders

Locations

2 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Multinational, investigator-initiated study of oral anticoagulation versus no anticoagulation for the prevention of stroke and other adverse cardiovascular events in patients with transient atrial fibrillation occurring transiently with stress and additional stroke risk factors.

Sponsor: Population Health Research Institute

You may qualify if…

  • ✓ 1. have ≥1 episode of clinically important AFOTS during any of the following conditions:
  • ✓ 1. noncardiac surgery in the past 35 days, with at least an overnight hospital admission aftersurgery;
  • ✓ 2. noncardiac day surgery resulting in a large enough physiological insult to be able to cause AFOTS, as judged by the local investigator; or
  • ✓ 3. acute medical illness requiring hospital admission in the past 35 days and resulting in a large enough physiological insult to be able to cause AFOTS, as judged by the local investigator;
  • ✓ 2. sinus rhythm at the time of randomization;
  • ✓ 3. any of the following high-risk criteria:
  • ✓ 1. age 55-64 years, and having either known cardiovascular disease, recent major vascular surgery, a CHA2DS2VASc score ≥3, or an elevated postoperative troponin level;
  • ✓ 2. age 65-74 years, and having either known cardiovascular disease, recent major vascular surgery, a CHA2DS2VASc score ≥2, or an elevated postoperative troponin level; OR

You may not qualify if…

  • ✕ 1. any cardiac diagnosis as the primary reason for hospital admission;
  • ✕ 2. history of documented chronic AF prior to noncardiac surgery;
  • ✕ 3. need for long-term systemic anticoagulation;
  • ✕ 4. ongoing need for long-term dual antiplatelet treatment;
  • ✕ 5. contraindication to oral anticoagulation;
  • ✕ 6. severe renal insufficiency (CrCl \<20 ml/min);
  • ✕ 7. severe liver cirrhosis (i.e., Child-Pugh Class C)
  • ✕ 8. acute stroke in the past 14 days;

Where it's recruiting

California

Los Angeles

Texas

Houston

Source: ClinicalTrials.gov · NCT03968393 · last updated 2026-01-12